Skip to main content

ZURICH HEART HOUSE


The Zurich Heart House creates and communicates new knowledge in the field of cardiovascular diseases and supports through its affiliation with the Center for Molecular Cardiology of the University of Zurich and as the seat of the "Foundation for Cardiovascular Research", it is one of the most impactful cardiology research and education centres in Europe. Its reach goes far beyond its home and thanks to its close collaboration with the London Heart House involves activities in the United Kingdom, Germany, Easter countries such as Aserbeijan, Georgia, Macedonia and Mexico.

Thanks to its global reach, the Zurich Heart House is a place of creative knowledge exchange between researchers, scientists, clinicians, practicing physicians, lecturers and staff. As a think tank, it is intended to strengthen Zurich as a location and serve as a service centre for doctors and patients with cardiovascular diseases.

Stay up to date with all our events - subscribe to our Newsletter HERE!


Upcoming Courses 2025

💗👉 Connect – Learn – Earn Credits 👈💗

 


Impressions from the 2025 Prevention Summit Berlin!

If you missed it—don’t worry, there’s more to come!
Check out our upcoming courses and register to learn, network, and earn credits.

 


Annual Report 2024*

*in German

ZHH News

TFL Youtube Channel

InsideCardiology: New Hot Topics in Cardiology Video!

Check out the new video on "Vaccination" with Professor Thomas F. Lüscher.

Watch the video and subscribe to InsideCardiology here!

Romania Society

Prof. Thomas F. Lüscher receives Honorary Membership

On the 18th of September 2025, Professor Thomas F. Lüscher president of the European Society of Cardiology, received a Distinguished Honorary Membership from the Romanian Society of Cardiology.

Congratulations!!!!

ImP

The micobiome is the new risk factor: and Imidazole Proprionate (IMP) is the new kid on the block - Short InsideCardiology Video

A new study, published in the European Heart Journal, establishes imidazole propionate (ImP), a gut microbiota-derived molecular driver of vascular inflammation and atherosclerosis, as a novel nontraditional cardiovascular risk factor in patients with coronary artery disease.

Watch the short video & get the full article here!
Subscribe to InsideCardiology here!

Cardiology News

Florian A. Wenzl Interview

ESC 2025 Interview: Florian A. Wenzl - How can AI transform cardiology?

How can AI transform cardiology? Florian A. Wenzl from the ESC Digital Cardiology and AI Committee shares insights on GRACE 3.0, precision diagnostics, and the barriers and opportunities in bringing AI into everyday clinical practice

Read the interview here!

World Heart Day 2025

World Heart Day 2025

📢 September 29th is the World Heart Day 2025!!! 📢 
💗 DON'T MISS A BEAT 💗 
Join the World Heart Federation's mission to make every heartbeat count, with better heart health and improved access to life-saving care. 

Learn more here!